Marlborough, MA (PRWEB) October 4, 2010
Navilyst Medical announced today the expansion of its peripherally inserted central catheter (PICC) portfolio with the US launch of its triple lumen Xcela PICC with PASV Valve Technology. The Xcela Family of power injectable PICCs is indicated for short or long-term peripheral access to the central venous system for intravenous therapy.
The new catheter offers an advanced solution for vascular access needs by combining the innovative design of the PASV Valve with the advanced material of the Xcela Power Injectable PICC. The triple lumen design provides clinicians with increased flexibility to perform a variety of procedures including the power injection of contrast media for CT imaging.
The PASV Valve Technology is designed to automatically resist backflow to reduce blood reflux that could lead to catheter-related complications. At a cost that is estimated to approach $100,000 per catheter-related complication, it has become a top priority for hospital administrators and infection control teams to reduce these complications.
The addition of a triple lumen catheter to Navilyst Medical’s Xcela PICC portfolio is a reflection of the company’s continued commitment to provide a complete range of products to deliver better device choices for clinicians.
About Navilyst Medical
Navilyst Medical Inc., headquartered in Marlborough, MA, is a leading provider of medical devices for vascular access and the diagnosis and treatment of non-vascular and vascular disease. Its breakthrough devices which include PASV® Valve Technology, expanded line of Xcela® Power Injectable PICCs and world-leading NAMIC® Fluid Management products, help hospitals to achieve safe, favorable outcomes for patients. The Company distributes its products worldwide and has its lead U.S. manufacturing facility in Glens Falls, NY. For more information, please visit: http://www.navilystmedical.com.
# # #